Literature DB >> 15293309

Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.

S Lossdörfer1, Z Schwartz, L Wang, C H Lohmann, J D Turner, M Wieland, D L Cochran, B D Boyan.   

Abstract

Titanium implant surfaces with rough microtopographies exhibit increased pullout strength in vivo suggesting increased bone-to-implant contact. This is supported by in vitro studies showing that as surface microroughness increases, osteoblast proliferation decreases whereas differentiation increases. Differentiation is further enhanced on microrough surfaces by factors stimulating osteogenesis including 1alpha,25(OH)2D3. Levels of PGE2 and TGF-beta1 are increased in cultures grown on rough microtopographies; this surface effect is enhanced synergistically by 1alpha,25(OH)2D3-treatment. PGE2 and TGF-beta1 regulate osteoclasts as well as osteoblasts, suggesting that surface microtopography may modulate release of other factors from osteoblasts that regulate osteoclasts. To test this hypothesis, we examined the effects of substrate microarchitecture on production of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL), which have been identified as a key regulatory system of bone remodeling. We also examined the production of 1alpha,25(OH)2D3, which regulates osteoblast differentiation and osteoclastogenesis. MG63 osteoblast-like cells were grown on either tissue culture plastic or titanium disks of different surface microtopographies: PT (Ra < 0.2 microm), SLA (Ra = 4 microm), and TPS (Ra = 5 microm). At confluence, cultures were treated for 24 h with 0, 10(-8) M or 10(-7) M 1alpha,25(OH)2D3. RANKL and OPG were determined at the transcriptional level by RT-PCR and real time PCR and soluble RANKL, OPG and 1alpha,25(OH)2D3 in the conditioned media were measured using immunoassay kits. Cell number was reduced on SLA and TPS surfaces and 1alpha,25(OH)2D3 caused further decreases. OPG mRNA levels increased on rougher surfaces and 1alpha,25(OH)2D3 treatment caused a further synergistic increase. While the cells expressed RANKL mRNA, levels were low and independent of surface microtopography. OPG protein was greater when cells were grown on SLA and TPS. 1alpha,25(OH)2D3 increased OPG by 50% on the smooth Ti surface but on SLA, 10(-8) M 1alpha,25(OH)2D3 caused a 100% increase and 10(-7) M 1alpha,25(OH)2D3 increased OPG by 200%. On TPS 10(-7) M 1alpha,25(OH)2D3 increased OPG 350%. Soluble RANKL was not detected in the conditioned media of any of the cultures. 1alpha,25(OH)2D3 was produced endogenously and levels were positively correlated with surface roughness. Thus, on surfaces with rough microtopographies, osteoblasts secrete factors that enhance osteoblast differentiation while decreasing osteoclast formation and activity. Copyright 2004 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15293309     DOI: 10.1002/jbm.a.30025

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  50 in total

1.  Mediation of osteogenic differentiation of human mesenchymal stem cells on titanium surfaces by a Wnt-integrin feedback loop.

Authors:  Rene Olivares-Navarrete; Sharon L Hyzy; Jung Hwa Park; Ginger R Dunn; David A Haithcock; Christine E Wasilewski; Barbara D Boyan; Zvi Schwartz
Journal:  Biomaterials       Date:  2011-06-01       Impact factor: 12.479

2.  Short-term and long-term effects of orthopedic biodegradable implants.

Authors:  Ami R Amini; James S Wallace; Syam P Nukavarapu
Journal:  J Long Term Eff Med Implants       Date:  2011

3.  Preparation of superhydrophilic microrough titanium implant surfaces by alkali treatment.

Authors:  Stefano Tugulu; Konrad Löwe; Dieter Scharnweber; Falko Schlottig
Journal:  J Mater Sci Mater Med       Date:  2010-08-20       Impact factor: 3.896

4.  The response of osteoblastic MC3T3-E1 cells to micro- and nano-textured, hydrophilic and bioactive titanium surfaces.

Authors:  S Lumetti; E Manfredi; S Ferraris; S Spriano; G Passeri; G Ghiacci; G Macaluso; C Galli
Journal:  J Mater Sci Mater Med       Date:  2016-02-17       Impact factor: 3.896

5.  Beta-1 integrins mediate substrate dependent effects of 1alpha,25(OH)2D3 on osteoblasts.

Authors:  Zvi Schwartz; Bryan F Bell; Liping Wang; Ge Zhao; Rene Olivares-Navarrete; Barbara D Boyan
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12-22       Impact factor: 4.292

6.  Influence of topography and hydrophilicity on initial oral biofilm formation on microstructured titanium surfaces in vitro.

Authors:  A Almaguer-Flores; R Olivares-Navarrete; M Wieland; L A Ximénez-Fyvie; Z Schwartz; B D Boyan
Journal:  Clin Oral Implants Res       Date:  2011-04-15       Impact factor: 5.977

7.  PLD bioactive ceramic films: the influence of CaO-P2O5 glass additions to hydroxyapatite on the proliferation and morphology of osteblastic like-cells.

Authors:  Gisela Marta Oliveira; Maria P Ferraz; Pío G González; Julia Serra; Betty Leon; Mariano Pèrez-Amor; Fernando J Monteiro
Journal:  J Mater Sci Mater Med       Date:  2007-12-06       Impact factor: 3.896

8.  The roles of Wnt signaling modulators Dickkopf-1 (Dkk1) and Dickkopf-2 (Dkk2) and cell maturation state in osteogenesis on microstructured titanium surfaces.

Authors:  Rene Olivares-Navarrete; Sharon Hyzy; Marco Wieland; Barbara D Boyan; Zvi Schwartz
Journal:  Biomaterials       Date:  2009-12-09       Impact factor: 12.479

9.  Direct and indirect effects of microstructured titanium substrates on the induction of mesenchymal stem cell differentiation towards the osteoblast lineage.

Authors:  Rene Olivares-Navarrete; Sharon L Hyzy; Daphne L Hutton; Christopher P Erdman; Marco Wieland; Barbara D Boyan; Zvi Schwartz
Journal:  Biomaterials       Date:  2010-01-06       Impact factor: 12.479

Review 10.  Perspectives on the role of nanotechnology in bone tissue engineering.

Authors:  Eduardo Saiz; Elizabeth A Zimmermann; Janice S Lee; Ulrike G K Wegst; Antoni P Tomsia
Journal:  Dent Mater       Date:  2012-08-14       Impact factor: 5.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.